Home

The Epsilon Group (TEG) is a modeling, analytics, and simulation services company committed to improving the understanding and management of disease with the ultimate goal of improving healthcare development and delivery. To this end, TEG provides proprietary bio-simulation services and software (SAAM II and T1DMS) which enable physiologically-based modeling of a wide range of problems in the lab and translational research.

TEG’s primary area of expertise is glucose-insulin metabolism in health and disease – including Type 1, Type 2 and Pre- Diabetes. As such, TEG offers simulation and consulting services for development and optimization of diabetes-specific treatments, protocols, and devices using a specialized (and unique) toolkit. This toolkit features the Type 1 Diabetes Metabolic Simulator (T1DMS) in conjunction with the FDA-accepted in silico patient population.

How TEG Solutions can help you

icon-pharma

Life Sciences and Pharma
Develop physiologically-based pharmacokinetic/pharmacodynamic models, test control algorithms, simulate clinical trials and examine outcomes to optimize therapy and eliminate non-viable solutions cost-effectively.

icon-healthcare

Healthcare
Simulate interventions and management of diabetes and related disease processes to optimize care delivery and disease management.

icon-education

Education
Utilize latest compartmental analysis and mathematical modeling techniques to educate future healthcare providers, engineers and researchers across many disciplines.